SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,516.08 -438.68
( -0.56%)

Global Indices

Nasdaq

53,904.84 -465.28
(-0.86%)

Dow Jones

7,729.00 -15.55
(-0.20%)

Hang Seng

65,663.80 -636.64
(-0.96%)

Nikkei 225

10,873.25 -15.05
(-0.14%)

Forex

USD-INR

95.23 -0.06
(-0.07%)

EUR-INR

109.68 -0.11
(-0.10%)

GBP-INR

127.98 -0.19
(-0.15%)

JPY-INR

0.60 0.00
(-0.60%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Walpar Nutritions Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

535385

INE0G2G01015

18.0826884

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

WALPAR

16.67

32.73

EPS(TTM)

Face Value()

Div & Yield %

2.09

Back

oxygenta pharmaceutical ltd

Rossari Biotech consolidated net profit rises 4.46% in the June 2026 quarter

Jul 18,2026

Net profit of Rossari Biotech rose 4.46% to Rs 35.10 crore in the quarter ended June 2026 as against Rs 33.60 crore during the previous quarter ended June 2025. Sales rose 28.23% to Rs 697.20 crore in the quarter ended June 2026 as against Rs 543.72 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	697.20	543.72	28
OPM %	11.56	12.48	-
PBDT	73.29	63.85	15
PBT	47.67	46.10	3
NP	35.10	33.60	4

78,516.08 -438.68 ( -0.56%)

53,904.84 -465.28 (-0.86%)

7,729.00 -15.55 (-0.20%)

65,663.80 -636.64 (-0.96%)

10,873.25 -15.05 (-0.14%)

95.23 -0.06 (-0.07%)

109.68 -0.11 (-0.10%)

127.98 -0.19 (-0.15%)

0.60 0.00 (-0.60%)